Code: MTA7495 | Publication Date: Aug 2025 |
This growth of heart transplant market is continued to rise in the upcoming years, driven by the increasing prevalence of end-stage heart diseases, advancements in surgical procedures, and improved post-transplant survival rates.
Heart transplant market is expanding its landscape throughout the years as hospitals are adopting enhanced organ preservation techniques, such as normothermic perfusion systems. Also, the market is noticing the rising emphasis on robotic-assisted surgeries and minimally invasive transplant procedures. Other trends such as AI-driven donor-recipient matching and genomic testing which are also emerging to improve transplant outcomes and reduce rejection.
Heart transplant market is developing with the years as the the development of ex-vivo heart perfusion systems are occurring that extend organ viability. Aside from this, research into xenotransplantation using genetically modified animal hearts is gaining momentum. Further, AI is being used to optimize donor selection and postoperative care, while blockchain is being explored to improve transparency in organ allocation.
Below is a comprehensive list of the leading market players driving growth in this sector:
Company Name | TransMedics, Inc. |
---|---|
Established Year | 1998 |
Headquarters | Massachusetts, United States |
Official Website | Click Here |
This company develops the Organ Care System which is a portable perfusion system used to maintain donor hearts in a near-living state during transport.
Company Name | Abbott Laboratories |
---|---|
Established Year | 1888 |
Headquarters | Illinois, United States |
Official Website | Click Here |
This company provides post-transplant care technologies and diagnostics including immunosuppressant monitoring tools critical to transplant success.
Company Name | XVIVO Perfusion AB |
---|---|
Established Year | 1998 |
Headquarters | Gothenburg, Sweden |
Official Website | Click Here |
This company specializes in organ preservation and perfusion systems that help improve heart and lung transplant outcomes.
Company Name | Medtronic plc |
---|---|
Established Year | 1949 |
Headquarters | Dublin, Ireland |
Official Website | Click Here |
This company offers a range of cardiac surgical instruments, monitoring systems, and post-transplant cardiac management devices.
Company Name | Paragonix Technologies |
---|---|
Established Year | 2010 |
Headquarters | Massachusetts, United States |
Official Website | Click Here |
This company manufactures advanced preservation transport systems for donor hearts, including the SherpaPak™ Cardiac Transport System.
Company Name | Novartis AG |
---|---|
Established Year | 1996 |
Headquarters | Basel, Switzerland |
Official Website | Click Here |
This company provides immunosuppressant drugs such as cyclosporine and tacrolimus, widely used to prevent organ rejection in heart transplant recipients.
Company Name | Pfizer Inc. |
---|---|
Established Year | 1849 |
Headquarters | New York, United States |
Official Website | Click Here |
This company engaged in developing and distributing post-transplant pharmaceutical therapies, including immunosuppressive and anti-infective agents.
Company Name | Thermo Fisher Scientific |
---|---|
Established Year | 2006 |
Headquarters | Massachusetts, United States |
Official Website | Click Here |
This company provides genetic testing tools and diagnostics used in compatibility testing and post-transplant immune monitoring.